Team of the Year award for Weston Park's radiotherapy remote monitoring service
20 January 2026
Press contact | claudia.blake@nhs.net
Weston Park Cancer Centre’s radiotherapy remote monitoring team have scooped the British Association of Urological Nurses’ Urology Team of the Year award.
The team won the top national award in recognition of a new remote monitoring service and nurse-led escalation clinic for prostate cancer patients on follow-up care after intensive radiotherapy treatment.
The service – which aligns with the NHS Ten Year Health Plan to bring care close to where patients are – enables patients to be reviewed and contacted promptly using remote technologies without the need for a routine hospital appointment. Short questionnaires track health data in real time along with Prostate Specific Antigen (PSA) blood test results.
So far, 1,900 patients have moved from traditional, hospital-based prostate cancer follow-up to the remote monitoring pathway. Patients are benefiting from timely interventions for side effects, psychological support, patient education, self-management, health management, rehabilitation, and treatment adherence from the convenience of their own homes whilst still under the care of the specialist, expert team.
As a result, a significant number of appointment slots have been released, helping to reduce waiting times and significantly enabling more effective use of consultant capacity in areas of greatest clinical need, such as the direct care of patients who do need to be seen in hospital.
Sweety Thengazhikathu, Uro Oncology Clinical Nurse Specialist at Sheffield Teaching Hospitals NHS Foundation Trust, said:
“Remote monitoring, managed by the specialist expertise of our team, is transforming care for thousands of prostate cancer patients in our region by allowing them to access faster, more convenient care, reducing anxiety and enabling them to access results without the worry and time of a hospital trip.”
Dr Omar Din, Uro-Oncology Clinical Lead at Sheffield Teaching Hospitals NHS Foundation Trust, said:
“This service has had a massive impact. For the 1,900 patients currently on follow up, they receive their results and support in a more much more timely manner. Another additional benefit is that it has assisted patients in the wider regional uro-oncology service who are now able to access consultant-led care faster than they would have otherwise.”
ENDS
